Cookie policy notice

By continuing to use this site you agree to our cookies policy below:
Since 26 May 2011, the law now states that cookies on websites can ony be used with your specific consent. Cookies allow us to ensure that you enjoy the best browsing experience.

This site is intended for health professionals only

At the heart of general practice since 1960

Cardiology - What's new (1 CPD hour)

Cardiology GPSI Dr Matt Hughes outlines five key recent developments and their impact on GP practice including NICE hypertension guidance, new anticoagulants for stroke prevention, generic atorvastatin and new data on exercise referral. Article onlyFull CPD module

 

Cardiology GPSI Dr Matt Hughes outlines five key recent developments and their impact on GP practice including NICE hypertension guidance, new anticoagulants for stroke prevention, generic atorvastatin and new data on exercise referral.

Learning objectives


To give a GP focused update on five important developments in the area of cardiology:

  • Latest NICE guidance on hypertension
  • Doubts over the value of exercise referral
  • Dabigatran and rivaroxaban as alternatives to warfarin in patients with atrial filbrillation
  • The implications of generic versions of atorvastatin
  • The four big unanswered questions on hypertension as identified by the European Society of Cardiology

This module is free for all registered members of Pulse Learning until 27 June 2012.

 

Article only | Full CPD module

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say